Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. NAVN
6. DFTX
7. CNC
8. KFY
9. SPY
10. MU

Go back to Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
(NASDAQ: LRMR) Delayed: 3.66 --0 (-0%)
Previous Close $3.66    52 Week High $ 
Open $3.66    52 Week Low $ 
Day High $3.66    P/E N/A 
Day Low $3.66    EPS $ 
Volume 3,604